Drugs Approved for Lung Cancer - National Cancer Institute

Drugs Approved for Lung Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for lung cancer. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used to treat lung cancer that are not listed here.

Drugs Approved for Non-Small Cell Lung Cancer (NSCLC)

Abitrexate (Methotrexate)
Alimta (Pemetrexed Disodium)
Avastin (Bevacizumab)
Bevacizumab
Carboplatin
Cisplatin
Erlotinib Hydrochloride
Folex (Methotrexate)
Folex PFS (Methotrexate)
Gefitinib
GEMCITABINE-CISPLATIN
Gemcitabine Hydrochloride
Gemzar (Gemcitabine Hydrochloride)
Iressa (Gefitinib)
Methotrexate
Methotrexate LPF (Methotrexate)
Mexate (Methotrexate)
Mexate-AQ (Methotrexate)
Paclitaxel
Paraplat (Carboplatin)
Paraplatin (Carboplatin)
Pemetrexed Disodium
Platinol (Cisplatin)
Platinol-AQ (Cisplatin)
Tarceva (Erlotinib Hydrochloride)
Taxol (Paclitaxel)


Drugs Approved for Small Cell Lung Cancer

Abitrexate (Methotrexate)
Etopophos (Etoposide Phosphate)
Etoposide
Etoposide Phosphate
Folex (Methotrexate)
Folex PFS (Methotrexate)
Hycamtin (Topotecan Hydrochloride)
Methotrexate
Methotrexate LPF (Methotrexate)
Mexate (Methotrexate)
Mexate-AQ (Methotrexate)
Toposar (Etoposide)
Topotecan Hydrochloride
VePesid (Etoposide)

open here to see/read/download the information of each drug listed:
Drugs Approved for Lung Cancer - National Cancer Institute